RESISTANT HYPERTENSION
Clinical trials for RESISTANT HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new RESISTANT HYPERTENSION trials appear
Sign up with your email to follow new studies for RESISTANT HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill may tame stubborn high blood pressure
Disease control CompletedThis study tested a new drug called baxdrostat in 218 adults whose high blood pressure remained high despite taking three or more medications. Participants received either baxdrostat or a placebo daily for 12 weeks. The main goal was to see if baxdrostat could lower average blood…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New shot could tame stubborn high blood pressure
Disease control CompletedThis study tested a new drug called XXB750 in 189 adults with resistant hypertension (high blood pressure that doesn't respond to standard treatments). Participants received different doses of the drug or a placebo as a shot under the skin, on top of their usual medications. The …
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
New pill may help when blood pressure meds aren't enough
Disease control CompletedThis study tested a new drug called baxdrostat in about 800 adults with high blood pressure that remains high despite taking two or more medications. Participants took either 1 mg, 2 mg, or a placebo pill daily for 12 weeks. The goal was to see if baxdrostat could safely lower bl…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 12, 2026 13:41 UTC
-
New pill aims to lower stubborn high blood pressure
Disease control CompletedThis study tested a new drug called baxdrostat in 326 adults whose high blood pressure was not controlled by two or more medications. Participants took either 1 mg, 2 mg of baxdrostat, or a placebo daily. The main goal was to see if baxdrostat could lower sitting systolic blood p…
Matched conditions: RESISTANT HYPERTENSION
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
Hidden hormone culprit found in many tough blood pressure cases
Knowledge-focused CompletedThis study looked at over 1,100 adults in the US whose high blood pressure stays high despite taking multiple medications. Researchers checked how many also have a hormone condition called endogenous hypercortisolism (too much cortisol). Participants provided blood and urine samp…
Matched conditions: RESISTANT HYPERTENSION
Sponsor: Corcept Therapeutics • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC
-
Tiny vessels, big clues: new study eyes hidden risk in stubborn hypertension
Knowledge-focused CompletedThis study looked at tiny blood vessels in the skin of people with resistant hypertension (high blood pressure that doesn't respond to multiple drugs). Researchers compared 111 participants to see if changes in these vessels could help predict heart risks. The goal was to find a …
Matched conditions: RESISTANT HYPERTENSION
Sponsor: National Institute of Cardiology, Laranjeiras, Brazil • Aim: Knowledge-focused
Last updated May 17, 2026 05:30 UTC